BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 8, 2005
View Archived Issues
Evidence suggests oxidized phospholipids may increase the risk of coronary artery disease
Read More
Genzyme reviews pipeline progress through quarter
Read More
ImaRx Therapeutics receives SBIR grant for targeted nanobubble development
Read More
CytoGenix and Aldevron collaborate on DNA vaccine technology
Read More
Lilly reports phase III results for ruboxistaurin mesilate
Read More
Phase III Flurizan trial enrolling on schedule
Read More
Imvamune protects against monkeypox in vivo
Read More
Good safety profile reported for GTI-2040 in advanced cancer
Read More
Quetiapine improves depression in patients with bipolar disorder
Read More
Phase I data on the safety profile of CTA-018 in patients with plaque psoriasis
Read More
Promising phase III data shows ISA-247 is safe and effective in plaque psoriasis
Read More
Prasugrel decreases the incidence of cardiac events in patients undergoing PCI
Read More
Oncotherapy Science and ConGenex to develop anticancer compounds
Read More
Japanese conditions for approval of Remicade relaxed
Read More
Gene therapy targeting survivin reverses PAH
Read More
Kissei launches thromboxane synthetase inhibitor Xanbon S in Japan
Read More
Diovan approved for high-risk heart attack survivors
Read More
Novel antiinfective agents reported in recent patents
Read More
New agents for cardiovascular diseases in early development
Read More
New potential cancer treatments disclosed in patent literature
Read More
Withdrawal of Infanrix HepB marketing authorization in Europe
Read More
Selective serotonin 5-HT6 antagonists improve memory formation in rats
Read More
Novel antihyperglycemic agent reduces hepatic glucose production
Read More